455 — Tianda Pharmaceuticals Share News
0.000.00%
- HK$191.35m
- HK$291.33m
- HK$322.95m
HK Exchange says 15 firms buy back shares
HK Exchange says 12 firms buy back shares
HK Exchange says 12 firms buy back shares
HK Exchange says nine firms buy back shares
Brief: Tianda Pharmaceuticals Posts FY Profit Attributable Of HK$10 Mln
HK Exchange says 13 firms buy back shares
HK Exchange says 13 firms buy back shares
HK Exchange says 15 firms buy back shares
HK Exchange says 16 firms buy back shares
HK Exchange says 11 firms buy back shares
HK Exchange says nine firms buy back shares
HK Exchange says seven firms buy back shares
Brief: Tianda Pharmaceuticals posts HY profit attributable of HK$2.6 million
Brief: Tianda Pharmaceuticals expects to record decline in HY consolidated net profit
Brief: Tianda Pharmaceuticals sees decline in HY consol net profit attributable
Brief: Tianda Pharmaceuticals' FY profit rises 89.4 pct
Brief: Tianda Pharmaceuticals says Fang Wen Quan has been appointed as managing director
Brief: Tianda Pharmaceuticals says Bristol-Myers Squibb to reacquire drug rights from unit
Brief: Tianda Pharmaceuticals says Liu Huijiang resigns as executive director